Category: Medications - Page 3

OTC Cold Medications and Warfarin: What You Must Avoid to Prevent Dangerous Bleeding
OTC Cold Medications and Warfarin: What You Must Avoid to Prevent Dangerous Bleeding
Dec, 8 2025 Medications Bob Bond
Warfarin users face serious bleeding risks from common OTC cold meds. Learn which ingredients to avoid, which are safe, and how to prevent dangerous interactions with simple, proven steps.
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
Dec, 6 2025 Medications Bob Bond
States are using MAC lists, mandatory substitution, PBM transparency, and price gouging laws to control Medicaid generic drug costs. These strategies save billions but face challenges like shortages and manufacturer pullouts.
Calcium Channel Blockers: How Metabolic Interactions Affect Drug Clearance and Safety
Calcium Channel Blockers: How Metabolic Interactions Affect Drug Clearance and Safety
Dec, 5 2025 Medications Bob Bond
Calcium channel blockers help millions manage blood pressure, but dangerous interactions with other drugs can cause life-threatening drops in blood pressure or heart rate. Learn how metabolism, grapefruit, kidney function, and genetics affect safety.
International Reference Pricing: How Countries Set Generic Drug Prices
International Reference Pricing: How Countries Set Generic Drug Prices
Dec, 3 2025 Medications Bob Bond
International reference pricing helps countries set lower prices for generic drugs by comparing costs across nations. Learn how it works, which countries use it, and why it sometimes causes shortages.
Therapeutic Failures: When Generic Medications Don't Work as Expected
Therapeutic Failures: When Generic Medications Don't Work as Expected
Dec, 1 2025 Medications Bob Bond
Generic drugs are supposed to be safe and effective alternatives to brand-name medications-but sometimes they fail. When a generic doesn’t work as expected, it can lead to serious health risks, especially with narrow therapeutic index drugs. Here’s what you need to know.
FDA Orange Book: How Approved Generic Drugs Are Listed
FDA Orange Book: How Approved Generic Drugs Are Listed
Nov, 25 2025 Medications Bob Bond
The FDA Orange Book lists approved generic drugs and shows which ones are therapeutically equivalent to brand-name drugs. It's the key resource for pharmacists, doctors, and insurers to ensure safe, affordable drug substitutions.
Antibiotic-Related Liver Injury: What You Need to Know About Hepatitis and Cholestasis
Antibiotic-Related Liver Injury: What You Need to Know About Hepatitis and Cholestasis
Nov, 23 2025 Medications Bob Bond
Antibiotics cause 64% of drug-induced liver injuries. Learn how amoxicillin-clavulanate, ciprofloxacin, and others trigger hepatitis or cholestasis, who’s at risk, and what to watch for - backed by 2024 clinical data.
Recent Drug Safety Communications and Medication Recalls: What You Need to Know
Recent Drug Safety Communications and Medication Recalls: What You Need to Know
Nov, 22 2025 Medications Bob Bond
Recent FDA drug safety alerts warn of serious risks with opioids, ADHD meds, allergy pills, and Alzheimer's treatments. Learn what's changed, why it matters, and how to stay safe.
Baseline CK Testing for Statins: When It’s Really Needed
Baseline CK Testing for Statins: When It’s Really Needed
Nov, 21 2025 Medications Bob Bond
Baseline CK testing before starting statins isn't needed for everyone-but for high-risk patients, it prevents unnecessary drug stops and avoids dangerous misdiagnoses. Here's when it actually matters.
Post-Marketing Pharmacovigilance: How New Medication Side Effects Are Found
Post-Marketing Pharmacovigilance: How New Medication Side Effects Are Found
Nov, 20 2025 Medications Bob Bond
Post-marketing pharmacovigilance catches dangerous side effects that clinical trials miss. Learn how real-world data, AI, and patient reports help uncover hidden drug risks after approval.